Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by WCM Investment Management LLC

WCM Investment Management LLC trimmed its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 59.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,422 shares of the biotechnology company's stock after selling 3,589 shares during the period. WCM Investment Management LLC's holdings in Axon Enterprise were worth $1,464,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Entropy Technologies LP acquired a new stake in Axon Enterprise in the 4th quarter worth about $2,250,000. Empirical Finance LLC boosted its stake in Axon Enterprise by 3.1% in the 4th quarter. Empirical Finance LLC now owns 1,070 shares of the biotechnology company's stock worth $636,000 after buying an additional 32 shares during the last quarter. Empowered Funds LLC boosted its stake in Axon Enterprise by 89.2% in the 4th quarter. Empowered Funds LLC now owns 1,871 shares of the biotechnology company's stock worth $1,112,000 after buying an additional 882 shares during the last quarter. Kingsview Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $212,000. Finally, Triasima Portfolio Management inc. acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $4,874,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 2.8 %

Shares of AXON traded up $18.71 during trading on Friday, reaching $683.41. The company's stock had a trading volume of 693,354 shares, compared to its average volume of 561,543. The company has a fifty day moving average of $623.22 and a two-hundred day moving average of $506.30. Axon Enterprise, Inc. has a twelve month low of $260.27 and a twelve month high of $698.67. The company has a market cap of $52.11 billion, a price-to-earnings ratio of 176.59, a P/E/G ratio of 6.79 and a beta of 1.05. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a research note on Monday, November 11th. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Finally, The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $542.15.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock valued at $5,631,561 in the last three months. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.